Veeva-Salesforce split: A catalyst for commercial transformation in life sciences

Life sciences companies can turn a forced choice into a strategic opportunity to revolutionize healthcare professional (HCP) engagement

The Veeva鈥揝alesforce split is forcing a decision for nearly every life sciences company 鈥� but it鈥檚 also opening the door to something bigger. In this point of view, we explore how this moment can spark a true transformation in HCP engagement, driven by smarter CRM strategy and emerging technologies.

Request a copy of our PoV to see how you can turn a forced choice into a strategic opportunity.

First Name *

First Name is not valid.

Last Name *

Last Name is not valid.

Email *

Email is not valid.

Company *

Company is not valid.

Job Title *

Job Title is not valid.

Country

Country is not valid.

I agree to 乌鸦传媒 collecting & processing my personal data to allow me to receive information on 乌鸦传媒 services. For further information, please see our Privacy Notice.

Slide to submit

Thanks for your submission.

We are sorry, the form submission failed. Please try again.